Last year in the UK over 60,000 cancer patients enrolled on clinical trials aimed at improving cancer treatments and making them available to all.
A study of 2 tests to find out if they can predict if early rectal cancer will come back after treatment (Ploidy and stroma study)
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at 2 tests using tissue samples to help predict the chances of rectal cancer coming back after treatment. Rectal cancer is also known as cancer of the rectum (back passage).
More about this trial
- ploidy test
- stroma test
- help work out the best treatment
- find out if the extra tests can help predict how well people do after treatment
- better predict whose cancer might come back
Who can enter
- have rectal cancer that can be removed with surgery
- can read and write in English
- are due to have or have had a type of surgery called trans anal endoscopic microsurgery (TEM)
- are at least 18 years old
The study team hope 150 people will take part in the study. It is for people having treatment at Oxford University Hospitals NHS Foundation Trust.
Some people might have already had surgery when they join the study. Or you might be due to have your routine surgery.
The surgeon takes the tissue sample during the operation. They send it to Norway to a specialist laboratory for the extra tests.
The trial team will compare the results from these 2 tests with other information about the cancer and how people do for at least 2 years after surgery.
You don’t have any extra hospital visits if you take part in this study.
How to join a clinical trial
Mr Chris Cunningham
Oslo University Hospital
OCCTOPUS – Oxford Colon Cancer Trust
Nuffield Department of Surgical Sciences
Oxford University Hospitals NHS Trust